stockrowStevanato Group S.p.A.
STVN Healthcare Medical Instruments & Supplies
Stevanato Group S.p.A.’s revenue for fiscal 2025 (year ended December 2025) was $1.3 billion, up 12.3% from fiscal 2024.
- Revenue
- +5.91%
- EPS
- +17.5%
- Free cash flow
- +4,089.9%
- Total debt
- +2.85%
Quarter to September 2026, against a year earlier
Follow STVN
Alert me
Stevanato Group S.p.A. (STVN) Net income
Stevanato Group S.p.A.'s net income for fiscal 2025 was $214.0M, up 23.4% from $173.4M in fiscal 2024. Over the twelve months to 30 September 2026 it was $227.4M. Over the past ten years it has ranged from $0.00 (fiscal 2017) to $214.0M (fiscal 2025) — the current reading is the highest in ten years. Stevanato Group S.p.A. ranks 12th of 51 Medical Instruments & Supplies companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2025 | $214.0M | 23.35% |
| FY2024 | $173.4M | (15.45%) |
| FY2023 | $205.2M | 3.77% |
| FY2022 | $197.7M | 0.86% |
| FY2021 | $196.0M | 78.22% |
| FY2020 | $110.0M | 149.95% |
| FY2019 | $44.0M | — |
| FY2017 | $0.00 | — |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $67.7M | 53.69% |
| Jun 2026 | $44.0M | (4.16%) |
| Mar 2026 | $45.9M | (34.18%) |
| Dec 2025 | $69.8M | 16.44% |
| 23 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| NVST Envista Holdings Corporation compare | $633.6M |
| STVN Stevanato Group S.p.A. | $227.4M |
| MMSI Merit Medical Systems, Inc. compare | $160.1M |
| ICUI ICU Medical, Inc. compare | $60.3M |
| ATRC AtriCure, Inc. compare | $14.9M |
| WRBY Warby Parker Inc. compare | $7.5M |
| PLSE Pulse Biosciences, Inc compare | −$83.8M |
| MMED MiniMed Group, Inc. compare | −$320.0M |
| TFX Teleflex Incorporated compare | −$1.0B |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on STVN
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement